Skip to main content
ON

OLEINITEC NORDIC AB

Bespoke Biologix specializes in stem cell therapies targeting cardiovascular, neurodegenerative, anti-aging, and autoimmune conditions through the application of regenerative medicine techniques. The company provides patients with personalized treatment options aimed at improving health outcomes and enhancing quality of life.

Sollentuna, SwedenFounded 202411500+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Many patients suffering from cardiovascular, neurodegenerative, anti-aging, and autoimmune conditions have limited treatment options, resulting in diminished health outcomes and reduced quality of life. Traditional medical interventions may not fully address the underlying causes or offer personalized solutions for these complex conditions.

Solution

Bespoke Biologix develops stem cell therapies that leverage regenerative medicine techniques to target the root causes of cardiovascular, neurodegenerative, anti-aging, and autoimmune diseases. The company focuses on providing personalized treatment options designed to improve patient health and enhance overall quality of life. By harnessing the regenerative potential of stem cells, Bespoke Biologix aims to offer innovative therapies that go beyond symptom management and promote tissue repair and functional restoration.

Target Audience

The primary target audience includes individuals suffering from cardiovascular, neurodegenerative, anti-aging, and autoimmune conditions seeking personalized and regenerative treatment options.

Features

  • Personalized stem cell therapies tailored to individual patient needs and conditions
  • Application of regenerative medicine techniques to address cardiovascular diseases
  • Targeted treatments for neurodegenerative disorders
  • Therapies aimed at slowing down the aging process and improving overall vitality
  • Stem cell-based interventions for autoimmune conditions
This profile is AI-generated and may contain inaccuracies.